| Mindful Heart Counseling Llc | |
|
1103 S Main St Kalispell MT 59901-5674 | |
| (406) 212-7866 | |
| Not Available |
| Full Name | Mindful Heart Counseling Llc |
|---|---|
| Speciality | Social Worker |
| Location | 1103 S Main St, Kalispell, Montana |
| Authorized Official Name and Position | Kathryn Jean Barrow (OWNER) |
| Authorized Official Contact | 4062127866 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Mindful Heart Counseling Llc Po Box 9034 Kalispell MT 59904-2034 Ph: (406) 212-7866 | Mindful Heart Counseling Llc 1103 S Main St Kalispell MT 59901-5674 Ph: (406) 212-7866 |
| NPI Number | 1013568492 |
|---|---|
| Provider Enumeration Date | 09/26/2019 |
| Last Update Date | 09/26/2019 |
| Medicare PECOS PAC ID | 0941632350 |
|---|---|
| Medicare Enrollment ID | O20191122000965 |
News Archive
Watson Pharmaceuticals, Inc., today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration on its Abbreviated New Drug Application for Valacyclovir Hydrochloride tablets, USP, in the 500 and 1000 mg strengths, the generic equivalent to GlaxoSmithKline, LLC's VALTREX tablets.
The risk of death resulting from heart attack is higher in people with schizophrenia than in the general public, according to scientists at the Centre for Addiction and Mental Health (CAMH) and the Institute for Clinical Evaluative Sciences (ICES).
Celgene Corporation today announced it has completed its acquisition of Abraxis BioScience, Inc. For each share of Abraxis common stock, Abraxis shareholders will receive (i) $58.00 in cash (ii) 0.2617 shares of Celgene common stock, and (iii) one tradeable Contingent Value Right (CVR), which entitles its holder to receive a pro rata share of potential payments for future regulatory milestones and commercial royalties.
Meda has signed an agreement to acquire ZpearPoint AS, including global rights to its main product, EB24, an OTC line for treating dental erosion. Dental erosion is a common, growing condition that impacts all ages and for which there is currently no effective treatment. The condition is estimated to affect 15-50% of the population and it is sometimes referred to as the "new caries".
"The patient will see you now." That is the new approach to health care for Blue Cross and Blue Shield of Minnesota's 10,000 employees and family members today, becoming the first Minnesotans - and the first in the continental U.S. - to have access to Online Care Anywhere(SM).
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013568492 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
| Provider Name | Kathryn J Barrow |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1215408661 PECOS PAC ID: 5991137317 Enrollment ID: I20191218002963 |
News Archive
Watson Pharmaceuticals, Inc., today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration on its Abbreviated New Drug Application for Valacyclovir Hydrochloride tablets, USP, in the 500 and 1000 mg strengths, the generic equivalent to GlaxoSmithKline, LLC's VALTREX tablets.
The risk of death resulting from heart attack is higher in people with schizophrenia than in the general public, according to scientists at the Centre for Addiction and Mental Health (CAMH) and the Institute for Clinical Evaluative Sciences (ICES).
Celgene Corporation today announced it has completed its acquisition of Abraxis BioScience, Inc. For each share of Abraxis common stock, Abraxis shareholders will receive (i) $58.00 in cash (ii) 0.2617 shares of Celgene common stock, and (iii) one tradeable Contingent Value Right (CVR), which entitles its holder to receive a pro rata share of potential payments for future regulatory milestones and commercial royalties.
Meda has signed an agreement to acquire ZpearPoint AS, including global rights to its main product, EB24, an OTC line for treating dental erosion. Dental erosion is a common, growing condition that impacts all ages and for which there is currently no effective treatment. The condition is estimated to affect 15-50% of the population and it is sometimes referred to as the "new caries".
"The patient will see you now." That is the new approach to health care for Blue Cross and Blue Shield of Minnesota's 10,000 employees and family members today, becoming the first Minnesotans - and the first in the continental U.S. - to have access to Online Care Anywhere(SM).
› Verified 9 days ago
News Archive
Watson Pharmaceuticals, Inc., today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration on its Abbreviated New Drug Application for Valacyclovir Hydrochloride tablets, USP, in the 500 and 1000 mg strengths, the generic equivalent to GlaxoSmithKline, LLC's VALTREX tablets.
The risk of death resulting from heart attack is higher in people with schizophrenia than in the general public, according to scientists at the Centre for Addiction and Mental Health (CAMH) and the Institute for Clinical Evaluative Sciences (ICES).
Celgene Corporation today announced it has completed its acquisition of Abraxis BioScience, Inc. For each share of Abraxis common stock, Abraxis shareholders will receive (i) $58.00 in cash (ii) 0.2617 shares of Celgene common stock, and (iii) one tradeable Contingent Value Right (CVR), which entitles its holder to receive a pro rata share of potential payments for future regulatory milestones and commercial royalties.
Meda has signed an agreement to acquire ZpearPoint AS, including global rights to its main product, EB24, an OTC line for treating dental erosion. Dental erosion is a common, growing condition that impacts all ages and for which there is currently no effective treatment. The condition is estimated to affect 15-50% of the population and it is sometimes referred to as the "new caries".
"The patient will see you now." That is the new approach to health care for Blue Cross and Blue Shield of Minnesota's 10,000 employees and family members today, becoming the first Minnesotans - and the first in the continental U.S. - to have access to Online Care Anywhere(SM).
› Verified 9 days ago
Flathead Valley Art Therapy, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 723 5th Ave E, 126, Kalispell, MT 59901 Phone: 406-212-7576 | |
Stefan C. Bean, Pc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 40 2nd St E, Suite 212, Kalispell, MT 59901 Phone: 406-253-0711 | |
Christine Hurst, Lcpc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1849 N Belmar Dr, Kalispell, MT 59901 Phone: 406-219-8689 | |
Advance Hope, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2 1st St E Ste 1, Kalispell, MT 59901 Phone: 406-212-7254 | |
Alida Troxell Therapy Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 108 W Reserve Dr, Kalispell, MT 59901 Phone: 406-366-6109 | |
Logan Health Newman Center Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 75 Claremont St Ste C, Kalispell, MT 59901 Phone: 406-758-5155 Fax: 406-758-5166 |